PubRank

M Alan Brookhart

Author PubWeight™ 194.05‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med 2005 8.44
2 High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology 2009 7.40
3 Clinical equivalence of generic and brand-name drugs used in cardiovascular disease: a systematic review and meta-analysis. JAMA 2008 6.63
4 The epidemiology of prescriptions abandoned at the pharmacy. Ann Intern Med 2010 3.78
5 Primary prevention of cardiovascular diseases with statin therapy: a meta-analysis of randomized controlled trials. Arch Intern Med 2006 3.75
6 Altitude and all-cause mortality in incident dialysis patients. JAMA 2009 3.62
7 Primary medication non-adherence: analysis of 195,930 electronic prescriptions. J Gen Intern Med 2010 3.57
8 Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly. Am J Epidemiol 2005 3.33
9 Compliance with osteoporosis medications. Arch Intern Med 2005 2.91
10 The comparative short-term effectiveness of iron dosing and formulations in US hemodialysis patients. Am J Med 2013 2.77
11 The increasing prevalence of atrial fibrillation among hemodialysis patients. J Am Soc Nephrol 2011 2.61
12 Statin adherence and risk of accidents: a cautionary tale. Circulation 2009 2.47
13 Evaluating uses of data mining techniques in propensity score estimation: a simulation study. Pharmacoepidemiol Drug Saf 2008 2.42
14 Relative effectiveness of osteoporosis drugs for preventing nonvertebral fracture. Ann Intern Med 2008 2.40
15 Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results. Med Care 2007 2.31
16 Evidence of sample use among new users of statins: implications for pharmacoepidemiology. Med Care 2014 2.22
17 Testosterone lab testing and initiation in the United Kingdom and the United States, 2000 to 2011. J Clin Endocrinol Metab 2014 2.18
18 Assessing health state utilities in elderly patients at cardiovascular risk. Med Decis Making 2006 2.12
19 Trends in glyburide compared with insulin use for gestational diabetes treatment in the United States, 2000-2011. Obstet Gynecol 2014 2.11
20 Does this patient with a pericardial effusion have cardiac tamponade? JAMA 2007 2.04
21 Osteoporosis telephonic intervention to improve medication regimen adherence: a large, pragmatic, randomized controlled trial. Arch Intern Med 2012 1.94
22 Trends in the use and outcomes of implantable cardioverter-defibrillators in patients undergoing dialysis in the United States. Am J Kidney Dis 2011 1.92
23 Measuring concurrent adherence to multiple related medications. Am J Manag Care 2009 1.88
24 Trends in drug prescribing for osteoporosis after hip fracture, 1995-2004. J Rheumatol 2007 1.80
25 Meta-analysis of the efficacy and safety of clopidogrel plus aspirin as compared to antiplatelet monotherapy for the prevention of vascular events. Am J Cardiol 2008 1.78
26 Effects of noncardiovascular comorbidities on antihypertensive use in elderly hypertensives. Hypertension 2005 1.77
27 Healthy user and related biases in observational studies of preventive interventions: a primer for physicians. J Gen Intern Med 2011 1.74
28 The implications of propensity score variable selection strategies in pharmacoepidemiology: an empirical illustration. Pharmacoepidemiol Drug Saf 2011 1.74
29 Instrumental variables I: instrumental variables exploit natural variation in nonexperimental data to estimate causal relationships. J Clin Epidemiol 2009 1.73
30 Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples. Am J Epidemiol 2011 1.72
31 Trends in the incidence, demographics, and outcomes of end-stage renal disease due to lupus nephritis in the US from 1995 to 2006. Arthritis Rheum 2011 1.68
32 Seizure outcomes following the use of generic versus brand-name antiepileptic drugs: a systematic review and meta-analysis. Drugs 2010 1.67
33 Doubly robust estimation of causal effects. Am J Epidemiol 2011 1.66
34 An information criterion for marginal structural models. Stat Med 2012 1.65
35 Influenza vaccine effectiveness in patients on hemodialysis: an analysis of a natural experiment. Arch Intern Med 2012 1.64
36 Simultaneous assessment of short-term gastrointestinal benefits and cardiovascular risks of selective cyclooxygenase 2 inhibitors and nonselective nonsteroidal antiinflammatory drugs: an instrumental variable analysis. Arthritis Rheum 2006 1.60
37 Kidney function and use of recommended medications after myocardial infarction in elderly patients. Clin J Am Soc Nephrol 2006 1.60
38 Patient, physician, and payment predictors of statin adherence. Med Care 2010 1.59
39 A randomized, controlled trial of in-home drinking water intervention to reduce gastrointestinal illness. Am J Epidemiol 2005 1.59
40 Instrumental variable analysis for estimation of treatment effects with dichotomous outcomes. Am J Epidemiol 2008 1.59
41 At Pitney Bowes, value-based insurance design cut copayments and increased drug adherence. Health Aff (Millwood) 2010 1.59
42 Trends in anemia care in older patients approaching end-stage renal disease in the United States (1995-2010). JAMA Intern Med 2014 1.58
43 Improving care of patients at-risk for osteoporosis: a randomized controlled trial. J Gen Intern Med 2007 1.56
44 Instrumental variables II: instrumental variable application-in 25 variations, the physician prescribing preference generally was strong and reduced covariate imbalance. J Clin Epidemiol 2009 1.56
45 Patient, physician, pharmacy, and pharmacy benefit design factors related to generic medication use. J Gen Intern Med 2007 1.50
46 Nonexperimental comparative effectiveness research using linked healthcare databases. Epidemiology 2011 1.50
47 Discontinuation and reinitiation patterns of osteoporosis treatment among commercially insured postmenopausal women. Int J Gen Med 2013 1.49
48 Effect of electronic prescribing with formulary decision support on medication use and cost. Arch Intern Med 2008 1.47
49 Design of cluster-randomized trials of quality improvement interventions aimed at medical care providers. Med Care 2007 1.47
50 The role of the c-statistic in variable selection for propensity score models. Pharmacoepidemiol Drug Saf 2010 1.45
51 Effect of the Women's Health Initiative on osteoporosis therapy and expenditure in Medicaid. J Bone Miner Res 2006 1.43
52 Adherence with osteoporosis practice guidelines: a multilevel analysis of patient, physician, and practice setting characteristics. Am J Med 2004 1.42
53 Changing patterns of anemia management in US hemodialysis patients. Am J Med 2012 1.39
54 More on reports of esophageal cancer with oral bisphosphonate use. N Engl J Med 2009 1.31
55 Risk of death and hospital admission for major medical events after initiation of psychotropic medications in older adults admitted to nursing homes. CMAJ 2011 1.26
56 Disease transmission models for public health decision making: analysis of epidemic and endemic conditions caused by waterborne pathogens. Environ Health Perspect 2002 1.24
57 Completeness of prescription information in US commercial claims databases. Pharmacoepidemiol Drug Saf 2013 1.23
58 Use of disease-modifying medications for rheumatoid arthritis by race and ethnicity in the National Ambulatory Medical Care Survey. Arthritis Care Res (Hoboken) 2012 1.16
59 Temporal trends in fracture rates and postdischarge outcomes among hemodialysis patients. J Am Soc Nephrol 2013 1.11
60 Effect of statin use on acute kidney injury risk following coronary artery bypass grafting. Am J Cardiol 2012 1.10
61 Patterns of rotavirus vaccine uptake and use in privately-insured US infants, 2006-2010. PLoS One 2013 1.09
62 State generic substitution laws can lower drug outlays under Medicaid. Health Aff (Millwood) 2010 1.08
63 Evolving statistical methods to facilitate evaluation of the causal association between erythropoiesis-stimulating agent dose and mortality in nonexperimental research: strengths and limitations. Am J Kidney Dis 2009 1.07
64 Dogmatists cannot learn. Epidemiology 2016 1.06
65 Calendar time-specific propensity scores and comparative effectiveness research for stage III colon cancer chemotherapy. Pharmacoepidemiol Drug Saf 2013 1.05
66 Suboptimal antidepressant use in the elderly. J Clin Psychopharmacol 2005 1.05
67 Impact of statin use on outcomes after coronary artery bypass graft surgery. Circulation 2008 1.04
68 Physician effectiveness in interventions to improve cardiovascular medication adherence: a systematic review. J Gen Intern Med 2010 1.03
69 Osteoporosis improvement: a large-scale randomized controlled trial of patient and primary care physician education. J Bone Miner Res 2007 1.03
70 Assessing residual confounding of the association between antipsychotic medications and risk of death using survey data. CNS Drugs 2009 1.02
71 Counterpoint: The Treatment Decision Design. Am J Epidemiol 2015 1.02
72 Hospitalization and skilled nursing care are predictors of influenza vaccination among patients on hemodialysis: evidence of confounding by frailty. Med Care 2013 1.01
73 The association between statin use and outcomes potentially attributable to an unhealthy lifestyle in older adults. Value Health 2011 1.01
74 Implications of M bias in epidemiologic studies: a simulation study. Am J Epidemiol 2012 1.01
75 Variation in drug prices at pharmacies: are prices higher in poorer areas? Health Serv Res 2008 1.00
76 The complex relation between bisphosphonate adherence and fracture reduction. J Clin Endocrinol Metab 2010 0.99
77 Variation in antipsychotic treatment choice across US nursing homes. J Clin Psychopharmacol 2012 0.99
78 Comparison of different approaches to confounding adjustment in a study on the association of antipsychotic medication with mortality in older nursing home patients. Am J Epidemiol 2011 0.98
79 An evaluation of the relationship between the implementation of a newly designed prescription drug label at Target pharmacies and health outcomes. Med Care 2009 0.97
80 Greater Epoetin alfa (EPO) doses and short-term mortality risk among hemodialysis patients with hemoglobin levels less than 11 g/dL. Pharmacoepidemiol Drug Saf 2009 0.97
81 Estimation of the standardized risk difference and ratio in a competing risks framework: application to injection drug use and progression to AIDS after initiation of antiretroviral therapy. Am J Epidemiol 2014 0.96
82 Psychotropic medication use for behavioral symptoms of dementia. Curr Neurol Neurosci Rep 2006 0.96
83 Intravenous iron supplementation practices and short-term risk of cardiovascular events in hemodialysis patients. PLoS One 2013 0.96
84 Exploring large weight deletion and the ability to balance confounders when using inverse probability of treatment weighting in the presence of rare treatment decisions. Pharmacoepidemiol Drug Saf 2012 0.96
85 Ventricular arrhythmias and cerebrovascular events in the elderly using conventional and atypical antipsychotic medications. J Clin Psychopharmacol 2007 0.95
86 A review of covariate selection for non-experimental comparative effectiveness research. Pharmacoepidemiol Drug Saf 2013 0.95
87 The relationship between focal erosions and generalized osteoporosis in postmenopausal women with rheumatoid arthritis. Arthritis Rheum 2009 0.94
88 Direct, indirect, total, and overall effectiveness of the rotavirus vaccines for the prevention of gastroenteritis hospitalizations in privately insured US children, 2007-2010. Am J Epidemiol 2014 0.94
89 Can improved prescription medication labeling influence adherence to chronic medications? An evaluation of the Target pharmacy label. J Gen Intern Med 2009 0.93
90 The role of prediction modeling in propensity score estimation: an evaluation of logistic regression, bCART, and the covariate-balancing propensity score. Am J Epidemiol 2014 0.92
91 A cross-national study of the persistence of antihypertensive medication use in the elderly. J Hypertens 2008 0.91
92 Educational outreach (academic detailing) regarding osteoporosis in primary care. Pharmacoepidemiol Drug Saf 2005 0.91
93 Trends in antibiotic treatment of acute otitis media and treatment failure in children, 2000-2011. PLoS One 2013 0.90
94 The role of disease transmission and conferred immunity in outbreaks: analysis of the 1993 Cryptosporidium outbreak in Milwaukee, Wisconsin. Am J Epidemiol 2005 0.90
95 Osteoporosis action: design of the healthy bones project trial. Contemp Clin Trials 2005 0.90
96 An evaluation of statistical approaches for analyzing physician-randomized quality improvement interventions. Contemp Clin Trials 2008 0.90
97 Risk. Am J Epidemiol 2015 0.89
98 Effect of pregnancy and the postpartum period on adherence to antiretroviral therapy among HIV-infected women established on treatment. J Acquir Immune Defic Syndr 2015 0.88
99 Predictors of stopping and starting disease-modifying antirheumatic drugs for rheumatoid arthritis. Arthritis Care Res (Hoboken) 2014 0.86
100 Using claims data to predict dependency in activities of daily living as a proxy for frailty. Pharmacoepidemiol Drug Saf 2014 0.86
101 Correlations of nursing home characteristics with prescription of osteoporosis medications. Bone 2011 0.84
102 Association between Initial Fluid Choice and Subsequent In-hospital Mortality during the Resuscitation of Adults with Septic Shock. Anesthesiology 2015 0.84
103 Effects of aggregation of drug and diagnostic codes on the performance of the high-dimensional propensity score algorithm: an empirical example. BMC Med Res Methodol 2013 0.83
104 Observation stays in administrative claims databases: underestimation of hospitalized cases. Pharmacoepidemiol Drug Saf 2014 0.83
105 Medicare part D's impact on antipsychotic drug use and costs among elderly patients without prior drug insurance. J Clin Psychopharmacol 2012 0.83
106 Relationships between driving distance, rheumatoid arthritis diagnosis, and disease-modifying antirheumatic drug receipt. Arthritis Care Res (Hoboken) 2014 0.82
107 Assessing the component associations of the healthy worker survivor bias: occupational asbestos exposure and lung cancer mortality. Ann Epidemiol 2013 0.82
108 Comparative short-term safety of bolus versus maintenance iron dosing in hemodialysis patients: a replication study. BMC Nephrol 2014 0.82
109 Acute kidney injury in statin initiators. Pharmacoepidemiol Drug Saf 2013 0.82
110 Meta-analyses involving cross-over trials: methodological issues. Int J Epidemiol 2009 0.82
111 High-risk patients' readiness to undergo BMD testing for osteoporosis diagnosis in Pennsylvania. Int Q Community Health Educ 2009 0.81
112 Validation of Medicaid Claims-based Diagnosis of Myocardial Infarction Using an HIV Clinical Cohort. Med Care 2015 0.81
113 Trends and variations in intravenous vitamin D use among hemodialysis patients in the United States. Ren Fail 2012 0.81
114 Practicable confidence intervals for current status data. Stat Med 2012 0.80
115 Patient-centered medical homes and oral anticoagulation therapy initiation. Med Care Res Rev 2013 0.80
116 Controlling Time-Dependent Confounding by Health Status and Frailty: Restriction Versus Statistical Adjustment. Am J Epidemiol 2015 0.80
117 Short look-back periods in pharmacoepidemiologic studies of new users of antibiotics and asthma medications introduce severe misclassification. Pharmacoepidemiol Drug Saf 2015 0.79
118 Sociodemographic, disease, health system, and contextual factors affecting the initiation of biologic agents in rheumatoid arthritis: a longitudinal study. Arthritis Care Res (Hoboken) 2014 0.79
119 A SAS macro for a clustered logrank test. Comput Methods Programs Biomed 2011 0.79
120 Impact of reimbursement changes on statin use among patients with diabetes in Austria. Wien Klin Wochenschr 2010 0.78
121 Confounding and control of confounding in nonexperimental studies of medications in patients with CKD. Adv Chronic Kidney Dis 2012 0.78
122 Altitude and the risk of cardiovascular events in incident US dialysis patients. Nephrol Dial Transplant 2012 0.78
123 Changing patterns of use of osteoporosis medications in the years after launch: implications for comparative effectiveness research. Pharmacoepidemiol Drug Saf 2013 0.78
124 Characterizing vaccine-associated risks using cubic smoothing splines. Am J Epidemiol 2012 0.77
125 Declining rates of work-related overexertion back injuries among union drywall installers in Washington State, 1989-2008: Improved work safety or shifting of care? Am J Ind Med 2013 0.77
126 Correction: Heterogeneity in Comparisons of Discontinuation of Tumor Necrosis Factor Antagonists in Rheumatoid Arthritis-A Meta-Analysis. PLoS One 2017 0.75
127 Trends in Anemia Management in Hemodialysis Patients with Cancer. Am J Nephrol 2015 0.75
128 A comparison of statistical approaches for physician-randomized trials with survival outcomes. Contemp Clin Trials 2011 0.75
129 The reply. Am J Med 2013 0.75
130 Pretransplantation erythropoiesis-stimulating agent hyporesponsiveness is associated with increased kidney allograft failure and mortality. Transplantation 2013 0.75
131 Comparative Effectiveness of Oxaliplatin Versus 5-flourouricil in Older Adults: An Instrumental Variable Analysis. Epidemiology 2015 0.75
132 A non-experimental study of oral anticoagulation therapy initiation before and after national patient safety goals. BMJ Open 2014 0.75
133 An empirical comparison of tree-based methods for propensity score estimation. Health Serv Res 2013 0.75
134 Comparison of pharmacy-based measures of adherence to antiretroviral therapy as predictors of virological failure. AIDS Behav 2015 0.75
135 On-label and off-label use of high-dose influenza vaccine in the United States, 2010-2012. Hum Vaccin Immunother 2015 0.75
136 Left Truncation Bias to Explain the Protective Effect of Smoking on Preeclampsia: Potential, But How Plausible? Epidemiology 2017 0.75
137 The Authors Respond. Epidemiology 2017 0.75
138 Guideline-conformity of initiation with oral hypoglycemic treatment for patients with newly therapy-dependent type 2 diabetes mellitus in Austria. Pharmacoepidemiol Drug Saf 2010 0.75
139 Percutaneous vertebroplasty among low income Medicare beneficiaries. Spine (Phila Pa 1976) 2007 0.75
140 Reply to taguri and matsuyama. Stat Med 2013 0.75
141 Approaches to inverse-probability-of-treatment--weighted estimation with concurrent treatments. J Clin Epidemiol 2013 0.75
142 Preschool motor skills following physical and occupational therapy services among non-disabled very low birth weight children. Matern Child Health J 2014 0.75